#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease recurrent T-cell lymphoma Glioma Central nervous system neoplasm Pyruvate kinase deficiency anaemia MELAS syndrome Ductal adenocarcinoma of pancreas Thrombotic thrombocytopenic purpura Cortical dysplasia Dent's disease Henoch-Schonlein purpura nephritis Iron overload Li-Fraumeni syndrome Hepatic angiosarcoma Anaemia More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis – Diagnostics Netherton’s syndrome – Diagnostics Haemolytic uraemic syndrome Nephroblastoma – Life with Disease Chronic granulomatous disease – Life with Disease Lennox-Gastaut syndrome – Treatment Epidermolysis bullosa – Life with Disease Cholangitis sclerosing – Diagnostics Idiopathic inflammatory myopathy – Basic Information Crigler-Najjar syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydrocortisone Ph. Eur. Diphenhydramine Hydroxi-Methionine Calcium Zinc Acetate Dihydrate Allo-501A Carboplatin Purified Egg Phospholipids Calcium Chloride Enalapril Clozapine Axitinib Olea Europaea Pollen Extract Sodium Lactate Estradiol Hemihydrate Cenegermin Bjt-778 Pasireotide Diaspartate Sodium Phosphate Dodecahydrate Olaptesed Pegol Peginterferon Beta-1A More therapies…

    Learn about Your Condition

    Mantle cell lymphoma Febrile neutropenia Ataxia telangiectasia Cystic fibrosis lung Cluster headache Adenocarcinoma gastric Meniscus operation Anal cancer recurrent Head and neck cancer Bronchostenosis Proteinuria Childhood asthma Incontinence Alveolar rhabdomyosarcoma Small fibre neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Central nervous system neoplasm
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Apl-101
    France Hungary Italy Spain

  • Clonidine Hydrochloride for Pain Relief During Eye Exams in Premature Infants with Retinopathy of Prematurity

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clonidine Hydrochloride
    Sweden

  • Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

    Recruiting

    4 1 1
    Investigated Drugs:
    • Vibegron
    Belgium Croatia Denmark Latvia Lithuania Norway +3

  • Study on Glofitamab, Venetoclax, and Zanubrutinib for Patients with Untreated or Relapsed High-Risk Mantle Cell Lymphoma

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • Glofitamab
    • Obinutuzumab
    Belgium France

  • Study on Acalabrutinib for Adults with Chronic Lymphocytic Leukemia and Heart Issues

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    Czechia Italy Poland Spain

  • Study on the Safety and Effectiveness of Tregs and Rituximab for Children with Early Stage Type 1 Diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    Investigated Drugs:
    • Clemastine Fumarate
    • Poltreg-T1D
    • Saline
    Poland
Previous Page
1 … 316 317 318 319 320 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!